Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 18;12:1287–1296. doi: 10.2147/JPR.S197168

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Cao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Intrathecal injection of AMTB decreased chronic constriction injury (CCI)-induced overexpression of PKC and elevated p-PKC/PKC value. (A) Compared with the Sham group, CCI increased the expression of PKC, p-PKC as well as the value of p-PKC/PKC. (B) In addition, CCI increased the expression of PKA and p-PKA although no significant difference was found for p-PKA/PKA between Sham and CCI rats. Compared with CCI group, intrathecal injection of AMTB decreased CCI-induced elevation of PKC and p-PKC/PKC value (A), but did not affect PKA, p-PKA and p-PKA/PKA (B). Data are expressed as mean±SD, n=3. ^*,#P<0.05 vs Sham group at the same time point, ^{▲, ●}P<0.05 vs CCI group.